Shield Therapeutics PLC Aktie
Deine Einschätzung
Shield Therapeutics PLC Aktie
Was spricht für und gegen Shield Therapeutics PLC in den nächsten Jahren?
Pro
Kontra
Rendite von Shield Therapeutics PLC im Vergleich
| Wertpapier | Ver.(%) | 1W | 1M | 1J | YTD | 3J | 5J |
|---|---|---|---|---|---|---|---|
| Shield Therapeutics PLC | 0,00 % | -2,89 % | -17,65 % | 121,05 % | -20,00 % | 32,28 % | -76,27 % |
| Pets At Home Group Ls 1 | -3,33 % | -6,42 % | -19,17 % | -27,69 % | -8,54 % | -47,50 % | -54,15 % |
| Card Factory plc | -2,62 % | -6,53 % | -11,58 % | -27,46 % | -9,61 % | -29,18 % | -16,73 % |
| Natural Grocers By Vit. Cot. | -0,92 % | -1,80 % | 2,83 % | -36,63 % | 1,87 % | 115,84 % | 59,12 % |
Kommentare
News
What Is the "Achilles Shield" and How Is Lockheed Martin Involved? Here's What Investors Need to Know.
Greece's air-defense capabilities will soon be getting an upgrade. That's the chief takeaway from the country's recent vote by the Special Permanent Parliamentary Committee on Armaments Programs and
5 Stocks and ETFs to Help Shield Your Portfolio During Volatility
The U.S. stock market has gotten off to an unsteady start this year. Outside a handful of defensive pockets, such as consumer staples and energy, most investors have felt the pressure. Elevated
Why Guardant Health Stock Surged Today
Shares of Guardant Health (NASDAQ: GH) rocketed 28% higher on Thursday after the precision oncology company reported outstanding growth metrics across its key product lines.
Image source: Getty



